Lee Y, Seo S, Jin YW, Jang S. Assessment of working environment and personal dosimeter-wearing compliance in industrial radiographers based on chromosome aberration frequencies.

Lee Y, Wang Q, Shuryak I, Brenner DJ, Turner HC. Development of a high-throughput γ-H2AX assay based on imaging flow cytometry.

Lee Y, Jin YW, Wilkins RC, Jang S. Validation of the dicentric chromosome assay for radiation biological dosimetry in South Korea.

Turner HC, Lee Y, Weber W, Melo D, Kowell A, Ghandhi SA, Amundson SA, Brenner DJ, Shuryak I. Effect of dose and dose rate on temporal γ-H2AX kinetics in mouse mononuclear cells in vivo following Cesium-137 administration.

Lee Y and Okayasu R. Strategies to enhance radiosensitivity to heavy ion radiation therapy.

Lee Y, Pujol Canadell M, Shuryak I, Perrier JR, Taveras M, Patel P, Koller A, Smilenov LB, Brenner DJ, Chen EI, Turner HC. Candidate Protein markers for radiation exposure in in vivo irradiated humanized mice model.

Lee Y, Sunada S, Hirakawa H, Fujimori A, Nickoloff JA, Okayasu R. TAS-116, a novel Hsp90 inhibitor, selectively enhances radio-sensitivity of human cancer cells to X-rays and carbon ion radiation.

Lee Y, Li HK, Masaoka A, Sunada S, Hirakawa H, Fujimori A, Nickoloff JA, Okayasu R. The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining.

Sunada S, Kanai H, Lee Y, Yasuda T, Hirakawa H, Liu C, Fujimori A, Uesaka M, Okayasu R. Nontoxic concentration of DNA-PK inhibitor NU7441 radio-sensitizes lung tumor cells with little effect on double strand break repair.

Cho YH, Lee JW, Woo HD, Lee S, Kim YJ, Lee Y, Shin S, Joung H, Chung HW. Protective Effect of Onion Extract on Bleomycin-Induced Cytotoxicity and Genotoxicity in Human Lymphocytes.